Abstract OBJECTIVE: Pharmacological intervention is an important means for the treatment of hypoxic-ischemic encephalopathy (HIE). As meta-analyses and randomized controlled clinical trials based on evidence-based medicine are able to provide the most reliable evidence for clinical practice, this study searched several databases in order to find the clinical evidence for the pharmacological treatment of neonatal HIE. METHODS: Meta-analyses and randomized (or quasi-randomized) controlled trials (RCT) for pharmacological therapy of HIE in term or late preterm newborn infants were searched from the databases of MEDLINE, EMBASE, Oxford Neonatal Group and Cochrane Library. The relevant literatures were statistically analyzed. RESULTS: Four Meta-analyses and thirteen RCTs were found to be involved in barbiturate, allopurinol, magnesium sulfate, mannitol, naloxone and dopamine therapy. None of the drugs could significantly decrease the mortality and the incidence of seizure or severe neurodevelopmental disabilities in newborn infants with HIE. CONCLUSIONS: Current clinical evidence indicates that no individual drug could decrease mortality and improve the neurodevelopmental outcomes in infants with HIE. Problems such as small scale in sampling and discrepancy in the identification of drug efficacy which exist in the clinical trials might lead to the uncertain effect of the drugs, and large sized and collaborative clinical trials are needed in the future.［Chin J Contemp Pediatr, 2009, 11 (9):740-744］
SHI Jing,XIONG Ying,MU De-Zhi. Clinical evidence for the pharmacological therapy in newborn infants with hypoxic-is-chemic encephalopathy[J]. 中国当代儿科杂志, 2009, 11(9): 740-744.
SHI Jing,XIONG Ying,MU De-Zhi. Clinical evidence for the pharmacological therapy in newborn infants with hypoxic-is-chemic encephalopathy[J]. CJCP, 2009, 11(9): 740-744.
［1］Evans DJ, Levene MI, Tsakmakis M. Anticonvulsants for preventing mortality and morbidity in full term newborns with perinatal asphyxia［J］. Cochrane Database Syst Rev, 2007(3):CD001240.
［2］Chaudhari T, McGuire W. Allopurinol for preventing mortality and morbidity in newborn infants with suspected hypoxic-ischaemic encephalopathy［J］. Cochrane Database Syst Rev, 2008(2):CD006817.
［3］McGuire W, Fowlie PW, Evans DJ. Naloxone for preventing morbidity and mortality in newborn infants of greater than 34 week' gestation with suspected perinatal asphyxia［J］. Cochrane Database Syst Rev, 2004(1):CD003955.
［4］Hunt R, Osborn D. Dopamine for prevention of morbidity and mortality in term newborn infants with suspected perinatal asphyxia［J］. Cochrane Database Syst Rev, 2002(3):CD003484.
［5］Vargas-Origel A, Espinosa-García JO, Muniz-Quezada E, Vargas-Nieto MA, Aguilar-Garcia G. Prevention of hypoxic-ischemic encephalopathy with high-dose, early phenobarbital therapy［J］. Gac Med Mex, 2004, 140(2):147-153.
［6］Hall RT, Hall FK, Daily DK. High-dose phenobarbital therapy in term newborn infants with severe perinatal asphyxia: a randomized, prospective study with three-year follow-up［J］. J Pediatr, 1998, 132(2):345-348.
［7］Singh D, Kumar P, Narang A. A randomized controlled trial of phenobarbital in neonates with hypoxic ischemic encephalopathy［J］. J Matern Fetal Neonatal Med, 2005, 18(6):391-395.
［8］Ruth V. Neonatal stress or distress［J］. J Perinat Med, 1991, 19（Suppl 1）:151-156.
［9］Goldberg RN, Moscoso P, Bauer CR, Bloom FL, Curless RG, Burke B, et al. Use of barbiturate therapy in severe perinatal asphyxia: a randomized controlled trial［J］. J Pediatr, 1986, 109(5):851-856.
［10］Vela F, Duran JA, Chunga F, Serrano JS, Valls A. Preventive treatment of convulsions in perinatal asphyxia［J］. An Esp Pediatr, 1987, 27(2):95-99.
［11］Van Bel F, Shadid M, Moison RM, Dorrepaal CA, Fontijn J, Monteiro L, et al. Effect of allopurinol on postasphyxial free radical formation, cerebral hemodynamics, and electrical brain activity［J］. Pediatrics, 1998, 101(2):185-193.
［12］Benders MJ, Bos AF, Rademaker CM, Rijken M, Torrance HL, Groenendaal F, et al. Early postnatal allopurinol does not improve short term outcome after severe birth asphyxia［J］. Arch Dis Child Fetal Neonatal Ed, 2006, 91(3):F163-165.
［13］Gunes T, Ozturk MA, Koklu E, Kose K, Gunes I. Effect of allopurinol supplementation on nitric oxide levels in asphyxiated newborns［J］. Pediatr Neurol, 2007, 36(1):17-24.
［14］Ichiba H, Tamai H, Negishi H, Ueda T, Kim TJ, Sumida Y, et al. Randomized controlled trial of magnesium sulfate infusion for severe birth asphyxia［J］. Pediatr Int, 2002, 44(5):505-509.
［15］Adhikari M, Moodley M, Desai PK. Mannitol in neonatal cerebral oedema［J］. Brain Dev, 1990, 12(3):349-351.
［16］Chernick V, Manfreda J, De Booy V, Davi M, Rigatto H, Seshia M. Clinical trial of naloxone in birth asphyxia［J］. J Pediatr, 1988, 113(3):519-525.
［17］DiSessa TG, Leitner M, Ti CC, Gluck L, Coen R, Friedman WF. The cardiovascular effects of dopamine in the severely asphyxiated neonate［J］. J Pediatr, 1981, 99(5):772-776.
［18］Levene MI, Gibson NA, Fenton AC, Papathoma E, Barnett D. The use of a calcium-channel blocker, nicardipine, for severely asphyxiated newborn infants［J］. Dev Med Child Neurol, 1990, 32(7):567-574.
［19］Juul SE, McPherson RJ, Bauer LA, Ledbetter KJ, Gleason CA, Mayock DE. A phase I/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety［J］. Pediatrics, 2008, 122(2):383-391.
［20］Fauchere JC, Dame C, Vonthein R, Koller B, Arri S, Wolf M, et al. An approach to using recombinant erythropoietin for neuroprotection in very preterm infants［J］. Pediatrics, 2008, 122(2):375-382.
［21］Calvert JW, Zhang JH. Pathophysiology of an hypoxic-ischemic insult during the perinatal period［J］. Neurol Res, 2005, 27(3):246-260.
［22］Boylan GB, Rennie JM, Chorley G, Pressler RM, Fox GF, Farrer K, et al. Second-line anticonvulsant treatment of neonatal seizures: a videoEEG monitoring study［J］. Neurology, 2004, 62(3):486-488.
［23］Whitelaw A. Systematic review of therapy after hypoxic-ischaemic brain injury in the perinatal period［J］. Semin Neonatol, 2000, 5(1):33-40.
［24］Sulzbacher S, Farwell JR, Temkin N, Lu AS, Hirtz DG. Late cognitive effects of early treatment with phenobarbital［J］. Clin Pediatr (Phila), 1999, 38(7):387-394.
［25］Holmes LB, Coull BA, Dorfman J, Rosenberger PB. The correlation of deficits in IQ with midface and digit hypoplasia in children exposed in utero to anticonvulsant drugs［J］. J Pediatr, 2005, 146(1):118-122.
［26］Dessens AB, Cohen-Kettenis PT, Mellenbergh GJ, Koppe JG, van De Poll NE, Boer K. Association of prenatal phenobarbital and phenytoin exposure with small head size at birth and with learning problems［J］. Acta Paediatr, 2000, 89(5):533-541.
［27］Bittigau P, Sifringer M, Genz K, Reith E, Pospischil D, Govindarajalu S, et al. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain［J］. Proc Natl Acad Sci USA, 2002, 99(23):15089-15094.
［28］Jacobs S, Hunt R, Tarnow-Mordi W, Inder T, Davis P. Cooling for newborns with hypoxic ischaemic encephalopathy［J］. Cochrane Database Syst Rev, 2007(4):CD003311.
［29］Roka A, Melinda KT, Vasarhelyi B, Machay T, Azzopardi D, Szabo M. Elevated morphine concentrations in neonates treated with morphine and prolonged hypothermia for hypoxic ischemic encephalopathy［J］. Pediatrics, 2008, 121(4):e844-849.
